Evidence map›Paper›PMID 28373189›Full record

ArticleAntimicrobial agents and chemotherapy2017

Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.

Joshua T Thaden, Lawrence P Park, Stacey A Maskarinec, Felicia Ruffin, Vance G Fowler, David van Duin

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 164 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Predictors of Mortality inPathogens (Basel, Switzerland) · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. CombattingAntibiotics (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Article
  15. Antibiotic-ResistantMicroorganisms · 2025
    Review
  16. Article
  17. Review
  18. Difficult-to-TreatAntibiotics (Basel, Switzerland) · 2025
    Review
  19. Observational
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joshua T ThadenDuke University Division of Infectious Diseases, Durham, North Carolina, USA.
Lawrence P ParkDuke University Division of Infectious Diseases, Durham, North Carolina, USA.
Stacey A MaskarinecDuke University Division of Infectious Diseases, Durham, North Carolina, USA.
Felicia RuffinDuke University Division of Infectious Diseases, Durham, North Carolina, USA.
Vance G FowlerDuke University Division of Infectious Diseases, Durham, North Carolina, USA vance.fowler@duke.edu.
David van DuinUniversity of North Carolina Chapel Hill Division of Infectious Diseases, Chapel Hill, North Carolina, USA.
Duke University · USUniversity of North Carolina at Chapel Hill · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Tri-Institutional Molecular Mycology and Pathogenesis Training ProgramT32AI052080 · NIAID · DUKE UNIVERSITY · PI ANDREW ALSPAUGH, JOSEPH HEITMAN · 2003 to 2026
$8.7M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
Mentoring Patient Oriented Research in Antibiotic-Resistant BacteriaK24AI093969 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2011 to 2020
$1.6M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS K24 AI093969NIAID NIH HHS T32 AI007517NIAID NIH HHS T32 AI052080NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

The impact of bacterial species on outcome in bloodstream infections (BSI) is incompletely understood. We evaluated the impact of bacterial species on BSI mortality, with adjustment for patient, bacterial, and treatment factors. From 2002 to 2015, all adult inpatients with monomicrobial BSI caused by

Indexed as

BacteremiaEnterobacteriaceaeGram-Negative BacteriaHumansProspective StudiesPseudomonas aeruginosaPseudomonas InfectionsStaphylococcus aureusbloodstream infectionsGram negativePseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID28373189
PMCPMC5444115
OpenAlexW2604646349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.